Table 2. Characteristics of patients undergoing first kidney transplantation for ESKD in Australia and New Zealand.
| Characteristics | Membranous nephropathy (n = 167) |
Other ESKD (n = 7,899) |
P value |
|---|---|---|---|
| Recipient Age (years) | 53[40–61] | 49[38–58] | 0.01 |
| 18–29 | 13(8%) | 838(11%) | 0.047a |
| 30–39 | 26(16%) | 1,362(17%) | |
| 40–49 | 34(20%) | 1,906(24%) | |
| 50–59 | 42(25%) | 2,153(27%) | |
| 60–69 | 45(27%) | 1,467(19%) | |
| ≥70 | 7(4%) | 173(2%) | |
| Male Recipient | 129(77%) | 4,932(62%) | <0.001 |
| Recipient Race | 0.61a | ||
| White | 143(86%) | 6,391(81%) | |
| Asian | 10(6%) | 736(9%) | |
| ATSI | 5(3%) | 229(3%) | |
| MPI | 6(3%) | 330(4%) | |
| Other | 3(2%) | 213(3%) | |
| Transplant era | 0.001 | ||
| 1998–2002 | 51(31%) | 1,533(19%) | |
| 2003–2007 | 45(27%) | 2,687(34%) | |
| 2008–2013 | 71(42%) | 3,679(47%) | |
| Smoking status at RRT entry | 0.37 | ||
| Current | 15(9%) | 884(11%) | |
| Former | 62(37%) | 2,558(33%) | |
| Never | 90(54%) | 4,435(56%) | |
| Diabetes mellitus | 9(5%) | 1,471(19%) | <0.001 |
| Chronic lung disease | 16(10%) | 383(5%) | 0.01 |
| Coronary artery disease | 25(15%) | 858(11%) | 0.09 |
| Peripheral vascular disease | 9(5%) | 507(6%) | 0.59 |
| Cerebrovascular disease | 8(5%) | 276(3%) | 0.37 |
| BMI (kg/m2) | 25.9[22.8–28.6] | 25.5[22.5–29.1] | 0.74 |
| Underweight (<18.5) | 5(3%) | 269(4%) | 0.67 |
| Normal weight (18.5–24) | 69(41%) | 3,343(42%) | |
| Overweight (25–29) | 64(38%) | 2,677(34%) | |
| Obese (≥30) | 29(18%) | 1,567(20%) | |
| Late referral | 25(15%) | 1,328(17%) | 0.51 |
| First RRT | 0.07 | ||
| Kidney transplantation | 29(17%) | 992(13%) | |
| Peritoneal dialysis | 46(28%) | 1,924(24%) | |
| Hemodialysis | 92(55%) | 4,983(63%) | |
| EBV seropositive | 139(89%) | 6,566(89%) | 0.88 |
| CMV seropositive | 115(71%) | 5,193(67%) | 0.33 |
| Male donor | 84(51%) | 4,022(52%) | 0.80 |
| Male donor for female receipt | 18(11%) | 1,602(20%) | 0.002 |
| Deceased donor | 96(57%) | 4,748(60%) | 0.47 |
| Subsequent allografts | 5(3%) | 224(2.84%) | 0.82 |
| 2nd | 5(3%) | 219(2.773%) | |
| 3rd or more | 0 | 5(0.063%) | |
| Follow-up years | 5.6[3.2–10.4] | 5.3[2.8–8.7] | 0.07 |
| Native kidney biopsy | 167(100%) | 3,730(47%) | <0.001 |
Abbreviations: ESKD, End-stage kidney diseases; ATSI, Aboriginal and Torres Strait Islander; MPI, Maori and Pacific Islander; RRT, Renal replacement therapy; BMI, body mass index; EBV, Epstein-Barr Virus; CMV, Cytomegalovirus
a Fisher’s test result.